Viemed Healthcare Inc VMD.OQ VMD.O is expected to show a rise in quarterly revenue when it reports results on August 6 for the period ending June 30 2025
The Lafayette Louisiana-based company is expected to report a 14.8% increase in revenue to $63.1 million from $54.97 million a year ago, according to the estimate from one analyst, based on LSEG data.
LSEG's mean analyst estimate for Viemed Healthcare Inc is for earnings of 8 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Viemed Healthcare Inc is $13.00, about 54.4% above its last closing price of $5.93
This summary was machine generated August 4 at 20:21 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Comments